Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Langsenlehner, T; Renner, W; Yazdani-Biuki, B; Langsenlehner, U.
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Breast Cancer Res Treat. 2008; 107(3): 459-460.
Doi: 10.1007/s10549-007-9564-1
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Langsenlehner Tanja
- Langsenlehner Uwe
- Co-Autor*innen der Med Uni Graz
- Renner Wilfried
- Yazdani-Biuki Babak
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Encouraged by recent studies on the MTHFR 677C>T polymorphism and breast cancer risk that suggested an association of the 677 TT genotype with increased breast cancer susceptibility in premenopausal women, we performed an analysis of the relationship between breast cancer risk and the MTHFR 677C>T polymorphism in 210 premenopausal breast cancer patients and sex- and agematched healthy control subjects. Our data show a trend for a higher MTHFR 677T allele frequency in breast cancer cases (61.9%) than in controls (51.5%, P = 0.082) supporting the results of previous studies.
- Find related publications in this database (using NLM MeSH Indexing)
- Breast Neoplasms - genetics
- Case-Control Studies -
- Female -
- Humans -
- Meta-Analysis as Topic -
- Methylenetetrahydrofolate Reductase (NADPH2) - genetics
- Polymorphism, Genetic -